The Prevalence of Cardiovascular Complications and Causes of AngioJet Failure: A Post-Marketing Surveillance Study Based on the MAUDE (Manufacturer and User Facility Device Experience) Database

Background and objective Aspiration thrombectomy devices, such as the AngioJet Solent Omni (Boston Scientific Corporation, Marlborough, MA) have been approved by the US FDA for the treatment of thrombi in peripheral arterial disease, venous disease, and AV fistulas. However, there is a dearth of rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Dandu, Chaitu, Patel, Dhruvil, Naughton, Ryan, Patel, Neel N, Alyami, Bandar, Najam, Maria, Bdiwi, Mustafa, Alhusain, Rashid, Sattar, Yasar, Alraies, M. Chadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471488/
https://www.ncbi.nlm.nih.gov/pubmed/37664247
http://dx.doi.org/10.7759/cureus.42824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471488/
https://www.ncbi.nlm.nih.gov/pubmed/37664247
http://dx.doi.org/10.7759/cureus.42824

Ejemplares similares